Home » Topics » BioWorld Science

BioWorld Science
RSS

4basebio and eTheRNA collaborate to evaluate linear DNA for mRNA production

Jan. 18, 2022

ZIP8 found to correlate with severe rheumatoid arthritis

Jan. 18, 2022

MCC-1381, a pan-HDAC inhibitor with promising anticancer activity

Jan. 18, 2022

EZH2 as a promising therapeutic target for prostate cancer

Jan. 18, 2022

Ono and Neurimmune expand drug discovery collaboration for neurodegenerative diseases

Jan. 18, 2022

Researchers suggest ZEB2 targeting as an approach for atherosclerosis

Jan. 18, 2022

VelociT mouse model for analyzing T-cell function in human disease

Jan. 18, 2022

PEGylated circularly permuted capsule depolymerase enzyme protects mice from anthrax infection

Jan. 18, 2022

SCN5A tied to drug-induced cardiac arrythmia

Jan. 18, 2022

TCR-modified T cells targeting TdT show antileukemia promise in vivo

Jan. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...